Molecular Partners Ag (MOLN) Income from Continuing Operations (2021 - 2025)
Historic Income from Continuing Operations for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$15.1 billion.
- Molecular Partners Ag's Income from Continuing Operations fell 11505936388.39% to -$15.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.0 billion, marking a year-over-year decrease of 2410271665.74%. This contributed to the annual value of -$61.4 million for FY2024, which is 1208.85% up from last year.
- As of Q3 2025, Molecular Partners Ag's Income from Continuing Operations stood at -$15.1 billion, which was down 11505936388.39% from $4.7 million recorded in Q2 2025.
- In the past 5 years, Molecular Partners Ag's Income from Continuing Operations ranged from a high of $165.2 billion in Q1 2022 and a low of -$16.3 billion during Q1 2023
- Its 5-year average for Income from Continuing Operations is $6.3 billion, with a median of -$17253.2 in 2025.
- In the last 5 years, Molecular Partners Ag's Income from Continuing Operations surged by 90218183697.23% in 2022 and then tumbled by 11505936388.39% in 2025.
- Molecular Partners Ag's Income from Continuing Operations (Quarter) stood at -$68.7 million in 2021, then soared by 277.85% to $122.2 million in 2022, then crashed by 100.77% to -$939914.8 in 2023, then surged by 977.59% to $8.2 million in 2024, then crashed by 182641.67% to -$15.1 billion in 2025.
- Its last three reported values are -$15.1 billion in Q3 2025, $4.7 million for Q2 2025, and -$17253.2 during Q1 2025.